We speculate that RANBP17 may suppress stromal CXCL13, CCL19 and CCL21 through exosome‐mediated mechanisms by reprogramming the cargo of cancer‐derived exosomes to include regulatory RNAs and proteins. Here, CCL21 is linked to cancer.